Paul Jank

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Thomas Karn, Carsten Denkert, Karsten E. Weber et al. · Annals of Oncology · 2020 · 233 citations

Early Tnbc, Tumor Mutational Burden, Cancer Immunosurveillance +9

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial

Alba Llop‐Guevara, Sibylle Loibl, Guillermo Villacampa et al. · Annals of Oncology · 2021 · 97 citations

Homologous Recombination Deficiency, Breast Oncology, Medicine +8

DNA methylation-based classification of sinonasal tumors

Philipp Jurmeister, Stefanie Glöß, Renée F. Roller et al. · Nature Communications · 2022 · 81 citations · Full text

Hotspot <i>ESR1</i> Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

Zheqi Li, Yang Wu, Megan E. Yates et al. · Cancer Research · 2022 · 78 citations · Full text

Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial

Sibylle Loibl, Denise Treue, Jan Budczies et al. · Clinical Cancer Research · 2019 · 67 citations